{
    "type": "ETC",
    "ucits": true,
    "replication_method": "synthetic",
    "swaps": true,
    "derivatives": true,
    "leverage": false,
    "inverse": false,
    "complex_factors": [
        "Synthetic replication via fully collateralised swap",
        "Exposure to commodity futures with rolling (contango/backwardation) effects",
        "Counterparty risk due to swap agreements",
        "Debt security structure (not equity)",
        "Collateralised debt security with counterparty collateral management"
    ],
    "classification": "complex",
    "supporting_data": "The WisdomTree Live Cattle product is an Exchange Traded Commodity (ETC) structured as a fully collateralised debt security that provides total return exposure to live cattle futures contracts by replicating the Bloomberg Commodity Live Cattle Subindex 4W Total Return Index through a synthetic replication method using fully funded swap agreements. The product explicitly uses swaps to gain exposure rather than physical ownership of the underlying commodity or futures contracts. The KIID and factsheet confirm the use of collateralised swap contracts with daily marked-to-market collateral held at a custodian bank, exposing investors to counterparty risk. The product is UCITS eligible but not a UCITS fund itself, and is structured as a debt security rather than an ETF. There is no leverage or inverse exposure, but the complexity arises from the synthetic replication, swap counterparty risk, and the nature of commodity futures exposure including roll costs and contango/backwardation effects, which can cause tracking error and make the product difficult to understand for retail investors. The risk indicator is medium (4/7), but the product carries specific warnings about counterparty risk, liquidity risk, and the absence of capital protection. The product is described as 'not simple and may be difficult to understand,' which aligns with MiFID II complexity criteria. Therefore, despite moderate risk rating and no leverage, the inherent use of swaps and synthetic replication classifies this ETC as complex under MiFID II."
}